{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:53:56Z","timestamp":1785902036075,"version":"3.56.0"},"reference-count":37,"publisher":"Oceanside Publications Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2022,7,1]]},"abstract":"<jats:p>Subcutaneous immunotherapy (SCIT) is a widely used therapy for allergic rhinitis and asthma. It is a useful adjunct to standard medical management of these conditions that can lead to long-term benefits and possible resolution of symptoms. The benefits of SCIT, particularly for children, include avoiding prolonged use and side effects from medications, preventing new aeroallergen sensitizations, and reducing the risk of developing asthma. The primary risks of SCIT include local and systemic reactions. Standard schedules for SCIT include advancing through multiple doses usually in four vials (diluted to 1:1000) on a weekly basis; however, there are benefits of using accelerated schedules, especially for children who need to coordinate school and parent work schedules. Special considerations for pediatric patients include fear of needles, avoiding discomfort with injections, consent, optimal injection scheduling, and difficulty communicating about symptoms during reactions in very young children. Overall, SCIT can be a safe and beneficial therapy for children.<\/jats:p>","DOI":"10.2500\/aap.2022.43.210114","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T04:31:26Z","timestamp":1657600286000},"page":"286-291","source":"Crossref","is-referenced-by-count":9,"title":["Pediatric subcutaneous allergen immunotherapy"],"prefix":"10.2500","volume":"43","author":[{"given":"Sonya","family":"Parashar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay M.","family":"Portnoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1355","reference":[{"key":"B1","article-title":"Allergies and hay fever fast stats"},{"key":"B2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/thx.2008.106609","article-title":"Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC)","volume":"64","author":"Lai","year":"2009","journal-title":"Thorax"},{"key":"B3","article-title":"Most recent national asthma data"},{"key":"B4","first-page":"CD001186","article-title":"Injection allergen immunotherapy for asthma","author":"Abramson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"B5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anai.2012.07.015","article-title":"Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy","volume":"109","author":"Stelmach","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1034\/j.1398-9995.2000.00191.x","article-title":"Long-term effects of specific immunotherapy, administered during childhood, in asthmatic patients allergic to either house-dust mite or to both house-dust mite and grass pollen","volume":"55","author":"Cools","year":"2000","journal-title":"Allergy"},{"key":"B7","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1056\/NEJMoa022363","article-title":"A longitudinal, population-based, cohort study of childhood asthma followed to adulthood","volume":"349","author":"Sears","year":"2003","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/all.12638","article-title":"Clinical contraindications to allergen immunotherapy: an EAACI position paper","volume":"70","author":"Pitsios","year":"2015","journal-title":"Allergy"},{"key":"B9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2500\/aap.2022.43.220033","article-title":"Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease","volume":"43","author":"Creticos","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"B10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B11","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/pai.12807","article-title":"EAACI guidelines on allergen immunotherapy: Prevention of allergy","volume":"28","author":"Halken","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"B12","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","article-title":"Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study","volume":"62","author":"Jacobsen","year":"2007","journal-title":"Allergy"},{"key":"B13","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/s41598-021-81558-0","article-title":"Respiratory tract infections in children with allergic asthma on allergen immunotherapy during influenza season","volume":"11","author":"Li","year":"2021","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12948-015-0021-0","article-title":"The perception of allergen-specific immunotherapy among pediatricians in the primary care setting","volume":"13","author":"Landi","year":"2015","journal-title":"Clin Mol Allergy"},{"key":"B15","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1542\/peds.2013-0343","article-title":"Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: A systematic review","volume":"131","author":"Kim","year":"2013","journal-title":"Pediatrics"},{"key":"B16","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1081-1206(10)60894-0","article-title":"Efficacy and safety of allergen immunotherapy in children","volume":"96","author":"Nelson","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13601-017-0159-6","article-title":"Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews","volume":"7","author":"Nurmatov","year":"2017","journal-title":"Clin Transl Allergy"},{"key":"B18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000503104","article-title":"Comparison of six different allergen extracts for subcutaneous specific immunotherapy in children: An open-labelled, prospective, controlled observational trial","volume":"180","author":"Kopp","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"B19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0091-6749(97)70069-1","article-title":"Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children","volume":"99","author":"Des Roches","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"B20","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1046\/j.1365-2222.2001.01161.x","article-title":"Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study","volume":"31","author":"Pajno","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"B21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1067\/mai.2002.121317","article-title":"Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study)","volume":"43","author":"Moller","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"B22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2500\/aap.2022.43.220035","article-title":"Safety of subcutaneous allergen immunotherapy","volume":"43","author":"Bernstein","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"B23","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jaip.2017.11.040","article-title":"Systemic Reactions in Pediatric Patients Receiving Standardized Allergen Subcutaneous Immunotherapy with and without Seasonal Dose Adjustment","volume":"6","author":"Albuhairi","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.anai.2016.01.015","article-title":"Local and systemic reactions to subcutaneous allergen immunotherapy: Ten years' experience in a pediatric clinic","volume":"116","author":"Nacaroglu","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1159\/000513158","article-title":"Subcutaneous allergen-specific immunotherapy is safe in pediatric patients with allergic rhinitis","volume":"182","author":"Pavon-Romero","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"B26","first-page":"75","article-title":"Are large local reactions a marker for systemic reactions to subcutaneous immunotherapy in children?","volume":"40","author":"Simsek","year":"2022","journal-title":"Asian Pac J Allergy Immunol"},{"key":"B27","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jaip.2020.01.003","article-title":"Controversies in allergy: Injectable epinephrine should be prescribed to all patients on subcutaneous aeroallergen immunotherapy","volume":"8","author":"Bernstein","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B28","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1159\/000514587","article-title":"Subcutaneous allergen immunotherapy in children: Real life compliance and effect of COVID-19 pandemic on compliance","volume":"182","author":"Aytekin","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"B29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.anai.2020.12.016","article-title":"A randomized trial of subcutaneous allergy immunotherapy in inner-city children with asthma less than 4 years of age","volume":"126","author":"de Vos","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.15586\/aei.v49i1.17","article-title":"Allergen-specific subcutaneous immunotherapy-pain evaluation in pediatric age","volume":"49","author":"Ferreira","year":"2021","journal-title":"Allergol Immunopathol (Madr)"},{"key":"B31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2500\/aap.2016.37.3961","article-title":"Comparison of pain during skin-prick testing, immunizations, and phlebotomy","volume":"37","author":"Coop","year":"2016","journal-title":"Allergy Asthma Proc"},{"key":"B32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/NMC.0b013e31825a8aa5","article-title":"Relief of pain during blood specimen collection in pediatric patients","volume":"37","author":"Inal","year":"2012","journal-title":"MCN Am J Matern Child Nurs"},{"key":"B33","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/PEC.0b013e318237ace4","article-title":"An integration of vibration and cold relieves venipuncture pain in a pediatric emergency department","volume":"27","author":"Baxter","year":"2011","journal-title":"Pediatr Emerg Care"},{"key":"B34","first-page":"CD005179","article-title":"Psychological interventions for needle-related procedural pain and distress in children and adolescents","volume":"10","author":"Uman","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"B35","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2500\/aap.2022.43.220017","article-title":"Allergen immunotherapy and shared decision-making","volume":"43","author":"Settipane","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"B36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/MPH.0b013e318180bc0d","article-title":"How do children and parents make decisions about pediatric clinical research?","volume":"30","author":"Varma","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"B37","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s40521-019-00212-3","article-title":"Accelerated immunotherapy: Why are we going so slow?","volume":"6","author":"Van Mason","year":"2019","journal-title":"Curr Treat Options Allergy"}],"container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2022\/00000043\/00000004\/art00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T10:11:22Z","timestamp":1676110282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2022.43.210114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7,1]]}},"alternative-id":["1088-5412(20220701)43:4L.286;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2022.43.210114","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,1]]}}}